Victory Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Buy |
|
|||||
|
2025
Q1 | $14.6K | Sell |
|
|||||
|
2024
Q4 | $20.5K | Sell |
|
|||||
|
2024
Q3 | $29.3K | Sell |
|
|||||
|
2024
Q2 | $28.6K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $12.2K | Buy |
|
|||||
|
2023
Q2 | $11.5K | Sell |
|
|||||
|
2023
Q1 | $22.6K | Sell |
|
|||||
|
2022
Q4 | $91.7K | Hold |
|
|||||
|
2022
Q3 | $130K | Buy |
|
|||||
|
2022
Q2 | $134K | Buy |
|
|||||
|
2022
Q1 | $140K | Buy |
|
|||||
|
2021
Q4 | $203K | Sell |
|
|||||
|
2021
Q3 | $272K | Sell |
|
|||||
|
2021
Q2 | $261K | Sell |
|
|||||
|
2021
Q1 | $308K | Buy |
|
|||||
|
2020
Q4 | $261K | Buy |
|
|||||
|
2020
Q3 | $241K | Sell |
|
|||||
|
2020
Q2 | $347K | Sell |
|
|||||
|
2020
Q1 | $1.66M | Buy |
|
|||||
|
2019
Q4 | $482K | Buy |
|
|||||
|
2019
Q3 | $40K | Sell |
|
|||||
|
2019
Q2 | $89K | Sell |
|
|||||
|
2019
Q1 | $86K | Hold |
|
|||||
|
2018
Q4 | $84K | Sell |
|
|||||
|
2018
Q3 | $156K | Sell |
|
|||||
|
2018
Q2 | $144K | Sell |
|
|||||
|
2018
Q1 | $369K | Buy |
|
|||||
|
2017
Q4 | $85K | Sell |
|
|||||
|
2017
Q3 | $82K | Hold |
|
|||||
|
2017
Q2 | $67K | Buy |
|
|||||
|
2017
Q1 | $79K | Buy |
|
|||||
|
2016
Q4 | $36K | Buy |
|
|||||
|
2016
Q3 | $47K | Buy |
|
|||||
|
2016
Q2 | $36K | Buy |
|
|||||
|
2016
Q1 | $35K | Buy |
|
|||||
|
2015
Q4 | $39K | Buy |
|
|||||
|
2015
Q3 | $23K | Buy |
|